Michael Exton
Chief Executive Officer at Lexicon Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Lexicon Pharmaceuticals Inc., 2 years.
Chief executive roles
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
569.8% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Lexicon Pharmaceuticals Inc. | Open-market purchase | +30,064 | $1.66 | $49,999 |
| Feb 28, 2026 | Lexicon Pharmaceuticals Inc. | Option exercise | +503,263 | — | — |
| Feb 28, 2026 | Lexicon Pharmaceuticals Inc. | Shares withheld for tax | −204,831 | $1.47 | $301,102 |
Questions about Michael Exton
What boards is Michael Exton on?
Michael Exton sits on the board of Lexicon Pharmaceuticals Inc.
What company is Michael Exton the CEO of?
Michael Exton has been Chief Executive Officer of Lexicon Pharmaceuticals Inc. since July 2024.
How long has Michael Exton served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.